Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb-Basics, Indications and Perspectives-A Scoping Review
Publicat a: | International journal of molecular sciences 22(2021)23, S. 12786 |
---|---|
Autors principals: | Köhler, Thomas (Autor), Schwier, Elke (Autor), Praxenthaler, Janina (Autor), Kirchner, Carmen (Autor), Henzler, Dietrich (Autor), Eickmeyer, Claas (Autor) |
Format: | Article |
Idioma: | English |
Publicat: |
2021
|
Matèries: | |
Accés en línia: | https://doi.org/10.3390/ijms222312786 Volltext |
Publicació relacionada: | In:
International journal of molecular sciences |
Ítems similars
-
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
per: Köhler, Thomas, et al.
Publicat: (2022) -
Hemoadsorption in the critically ill - Final results of the International CytoSorb Registry
per: Hawchar, Fatime, et al.
Publicat: (2022) -
High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock : a retrospective cohort study
per: Schultz, Philipp, et al.
Publicat: (2021) -
Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement
per: Köhler, Thomas, et al.
Publicat: (2021) -
Implementation of anesthesia quality indicators in Germany : A prospective, national, multicenter quality improvement study
per: Ziemann, S., et al.
Publicat: (2020)